Artificial intelligence unlocks maximum data from our cellular image datasets.
Design. Execute. Discover. Recursion.
Our entirely automated approach allows us to achieve the industrialization of discovery biology.
Revealing genetics through the lens of the Recursion platform, we can illuminate a map of human biology.
We collect massive amounts of data alongside rigorously defined control and test variations to yield rich biological discoveries each week. Our platform performs large-scale analytics and artificial intelligence model training on the characteristics of hundreds of cellular phenotypes across biology to develop computational “fingerprints,” or Phenoprints™, of a wide variety of biological perturbations. We analyze images from over 10 million cells per week, and add these images to our nearly 1 petabyte database of relatable biological image data.We’ve used these massive datasets to construct an industry-leading portfolio of high-value cellular models that provide insight into hundreds of monogenic loss-of-function diseases, fibrosis, inflammatory and immunological diseases, efficacy and toxicity scoring, dose-response characteristics, and target discovery and prediction. Our design rigor and scalable platform generate large numbers of high-quality lead candidates from our internal drug library and our partners’ libraries, as well as biological insights that contribute to quickly de-risk discovery programs.
The Vision Revealed Over Time